PARO is an evidence-based neurological therapeutic robot that has been an FDA cleared Class II Medical Device in the US, since 2009. PARO is developed in an FDA regulated medical device manufacturing facility in Japan by AIST, a leading Japanese industrial automation pioneer. It allows the documented benefits of animal therapy to be administered to patients in environments such as hospitals and extended care facilities where live animals present treatment or logistical difficulties. Symptoms from PTSD, dementia, or Alzheimers, such as wandering, self-isolation, anxiety, depression, aggression, loneliness, pet loss, agitation, boredom, grieving, and sundowning can be addressed by clinical or practical application of PARO interactions. It is also helpful for treating isolation, insomnia, and Long COVID syndrome.